Patents by Inventor Colin Gardner

Colin Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230382632
    Abstract: The present invention relates generally to the field of beverage capsules. In particular, the present invention relates to a biodegradable top membrane of a beverage capsules. The biodegradable top membrane of a beverage capsule is pierceable by injection means of a beverage preparation machine which are adapted to inject an extraction liquid under pressure inside a closed chamber containing a mass of soluble and/or extractable food material. Remarkably, the top membrane possesses the necessary physical properties to be useful for beverage capsules while being biodegradable. The biodegradable top membrane for a beverage capsule comprises at least one polyhydroxyalkanoate (PHA).
    Type: Application
    Filed: October 5, 2021
    Publication date: November 30, 2023
    Inventors: LISE ZEBOUDJ, COLIN GARDNER NEILL, VIOLETTE BOURG
  • Patent number: 11576859
    Abstract: Gastric residence systems comprising therapeutic agent formulations for sustained gastric release of therapeutic agents are disclosed, as well as methods for using such systems. The systems are characterized by use of a dispersant in the formulations, which improves the burst release characteristics and long-term release rate characteristics of the systems. Milling of therapeutic agent can also be performed to prepare agent particles of desired size.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: February 14, 2023
    Assignee: Lyndra Therapeutics, Inc.
    Inventors: Rosemary Kanasty, Andrew Bellinger, Colin Gardner, Tyler Grant, Saumya Moorthy
  • Publication number: 20200146979
    Abstract: The invention provides gastric residence systems, or components of gastric residence system such as segments or elongate members of gastric residence systems, with release rate-modulating films and methods for making and using such systems. The release rate-modulating films provide good control over release of agents (such as therapeutic, diagnostic, or nutritional agents) present in the gastric residence system. The films also permit higher drug loading in the gastric residence systems and components of gastric residence systems while maintaining good control over release of agents. Some embodiments of the films can provide resistance against burst release of agent upon exposure to alcohol.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 14, 2020
    Inventors: Rosemary KANASTY, Nupura BHISE, Stephen ZALE, Bennett CARTER, Jung Hoon YANG, Andrew BELLINGER, Susan LOW, James WRIGHT, David ALTREUTER, Colin GARDNER
  • Publication number: 20190262265
    Abstract: The invention provides gastric residence systems with configurations and geometrical dimensions that allow for improved shelf life during prolonged storage, and optimal residence properties when the systems are deployed in the stomach of a patient.
    Type: Application
    Filed: December 7, 2016
    Publication date: August 29, 2019
    Inventors: Andrew BELLINGER, Rosemary KANASTY, Tyler GRANT, Colin GARDNER
  • Publication number: 20180311154
    Abstract: Gastric residence systems comprising therapeutic agent formulations for sustained gastric release of therapeutic agents are disclosed, as well as methods for using such systems. The systems are characterized by use of a dispersant in the formulations, which improves the burst release characteristics and long-term release rate characteristics of the systems. Milling of therapeutic agent can also be performed to prepare agent particles of desired size.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 1, 2018
    Inventors: Rosemary KANASTY, Andrew BELLINGER, Colin GARDNER, Tyler GRANT, Saumya SINGH
  • Publication number: 20100210027
    Abstract: Preformulation analysis and optimization comprising dissolution strudies.
    Type: Application
    Filed: November 4, 2003
    Publication date: August 19, 2010
    Inventors: Hongming Chen, Hector Guzman, Colin Gardner
  • Publication number: 20070087052
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: March 27, 2006
    Publication date: April 19, 2007
    Inventors: Ashok Katdare, Kenneth Kramer, Colin Gardner
  • Publication number: 20060188940
    Abstract: The present invention concerns a method, apparatus (array assembly), and system for fabricating and formulating hydrogels using combinatorial techniques; a hydrogel array fabricated using the method, apparatus, and/or system of the invention; and methods and systems for testing the properties of arrayed hydrogels, such as bulk and interfacial mechanical properties.
    Type: Application
    Filed: February 21, 2006
    Publication date: August 24, 2006
    Inventors: Michael Cima, Sherri Colvin, Colin Gardner, Javier Gonzalez-Zugasti, J. Gyory, Wendy Pryce-Lewis
  • Publication number: 20060148877
    Abstract: Liquid formulations of celecoxib have been found to provide faster pain relief than conventional solid formulations of celecoxib. The present invention provides combinations of excipients in which celecoxib is highly soluble for formulation as pharmaceutical compositions.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 6, 2006
    Applicant: TransForm Pharmaceuticals, Inc.
    Inventors: Steven Bernstein, Hongming Chen, Colin Gardner, Meegan LeMott, Szu-Wen Wang
  • Publication number: 20060111345
    Abstract: In a first aspect, the present invention includes a pharmaceutical composition comprising a COX-2 inhibitor and a diuretic. Such a composition can be used to treat a patient suffering from, for example, osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, pain, primary dysmenorrhea, migraine, or colorectal polyps. The disclosure provides methods as well as pharmaceutical compositions and formulations useful in the treatment and/or prevention of one or more of several conditions described herein.
    Type: Application
    Filed: November 21, 2005
    Publication date: May 25, 2006
    Applicant: Transform Pharmaceuticals, Inc.
    Inventors: Reynold Spector, Colin Gardner
  • Publication number: 20060057734
    Abstract: Preformulation analysis and optimization comprising dissolution strudies.
    Type: Application
    Filed: November 4, 2003
    Publication date: March 16, 2006
    Inventors: Hongming Chen, Hector Guzman, Colin Gardner
  • Publication number: 20060034921
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: October 19, 2005
    Publication date: February 16, 2006
    Inventors: Ashok Katdare, Kenneth Kramer, Colin Gardner
  • Publication number: 20060003782
    Abstract: A system and method for providing voice or data connectivity to multiple aircraft or communication devices via a single telephone number. The initial call placed by a caller can be to a direct global number, or can be forwarded to the direct global number via a toll-free access number. A caller is prompted to select from an automated selection of aircraft, vessels, communication devices, or other available devices or units. Based upon the selection, the call is routed to the single global number for that selection. A caller then hears a greeting that identifies the aircraft, vessel, or device selected and provides the handset, data service, or other options available. After a caller makes a selection, call connectivity is established.
    Type: Application
    Filed: June 27, 2005
    Publication date: January 5, 2006
    Inventors: James Jensen, Colin Gardner-Springer
  • Patent number: 6970704
    Abstract: An automated communication system for communicatively connecting a caller with a communications device to an space craft. The system includes a port for accepting a call and a call management program that uses a spacecraft identifier to automatically effect the communication to the space craft via a ground earth station and a satellite. The satellite retransmits the communication to a dedicated spacecraft receiver in the space craft. The system provides Internet-based call monitoring and billing capabilities. The system reduces cost and overall connection time by using the Internet to verify the spacecraft's flying status through the ground station databases before initiating a call.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: November 29, 2005
    Assignee: Satcom Direct, Inc.
    Inventors: James W. Jensen, Daniel Linnihan, Colin Gardner-Springer, Amy Lynn Stifter
  • Publication number: 20040106098
    Abstract: Methods and systems are disclosed that can be used for the automated preparation and analysis of mixtures comprising a compound-of-interest (e.g., the active ingredient of a pharmaceutical composition) and one or more excipients. Specific embodiments of the invention are particularly suited for the precise preparation and screening of small amounts of excipients, compounds-of-interest, and mixtures thereof. The invention is also well suited for the preparation and screening of small amounts of mixtures comprising high concentrations of compounds-of-interest.
    Type: Application
    Filed: November 4, 2003
    Publication date: June 3, 2004
    Applicant: TransForm Pharmaceuticals
    Inventors: Hongming Chen, Hector Guzman, Colin Gardner
  • Publication number: 20020111165
    Abstract: An automated communication system for communicatively connecting a caller with a communications device to an space craft. The system includes a port for accepting a call and a call management program that uses a spacecraft identifier to automatically effect the communication to the space craft via a ground earth station and a satellite. The satellite retransmits the communication to a dedicated spacecraft receiver in the space craft. The system provides Internet-based call monitoring and billing capabilities. The system reduces cost and overall connection time by using the Internet to verify the spacecraft's flying status through the ground station databases before initiating a call.
    Type: Application
    Filed: December 21, 2001
    Publication date: August 15, 2002
    Inventors: James W. Jensen, Daniel Linnihan, Colin Gardner-Springer, Amy Lynn Stifter
  • Patent number: 6400945
    Abstract: An automated communication system for communicatively connecting a caller by means of a telephone to an space craft includes a port for accepting a telephonic call related to a specific space craft from the caller and having a machine readable call management program, the call management program automatically effecting a telephonic communication to at least one selected ground earth station responsive thereto. The ground earth station effects communication with at least one known satellite in an earth orbit responsive to the received communication from the port. And, the satellite retransmits the ground earth station communications to the space craft for reception by a dedicated receiver in the space craft, thereby establishing a telephonic communications link from the caller to the specific space craft. A method and a program for effecting global communications between a ground station, a plurality of global satellite systems and a space craft are included.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: June 4, 2002
    Assignee: Satcom Direct, Inc.
    Inventors: James W. Jensen, Daniel Linnihan, Colin Gardner-Springer